Syndax Pharmaceuticals Inc (SNDX)
$13.65 -3.53% Close Oct 30, 2026 Live
Syndax Pharmaceuticals stock today
Syndax Pharmaceuticals closed at $13.65 on October 30, 2026, down 3.53% on the day. Over the past year it returned +1.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.21 billion.
$15.00$20.00$25.00
NovJan 2026MarMayJulSep
| Period | SNDX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -27.4% | -0.9% |
| 3 months | -29.9% | +2.1% |
| Year to date | -35.0% | +11.7% |
| 1 year | +1.9% | +12.4% |
| 3 years | +4.6% | +88.5% |
| 5 years | -29.8% | +76.0% |
Key statistics
- Market value
- $1.21B
- Price / sales
- 4.8
- 52-week range
- $12.90 to $25.15
- Next report
- Nov 2, 2026
About Syndax Pharmaceuticals
Syndax Pharmaceuticals develops drugs targeting histone deacetylases and other epigenetic targets.
Sector: Health Care
More on Syndax Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +628% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $1,145 today
No forecast, no recommendation. This page describes Syndax Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.